Skip to Content
Merck
CN

36777

2′,3′-Dideoxyinosine

≥95% (HPLC)

Synonym(s):

ddI, ddIno

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C10H12N4O3
CAS Number:
Molecular Weight:
236.23
UNSPSC Code:
12161700
Beilstein/REAXYS Number:
3619529
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

≥95% (HPLC)

impurities

≤1% water

mp

193-195 °C

application(s)

agriculture
environmental

storage temp.

2-8°C

SMILES string

OC[C@@H]1CC[C@@H](O1)n2cnc3C(=O)NC=Nc23

InChI

1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1

InChI key

BXZVVICBKDXVGW-NKWVEPMBSA-N

Other Notes

Experimental anti-retroviral agent

Regulatory Information

新产品

This item has


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.
G Ahluwalia et al.
Biochemical pharmacology, 36(22), 3797-3800 (1987-11-15)
J E Dahlberg et al.
Proceedings of the National Academy of Sciences of the United States of America, 84(8), 2469-2473 (1987-04-01)
Certain dideoxynucleosides have been shown to markedly inhibit the infectivity of human T-lymphotropic virus type III/lymphadenopathy-associated virus, the causative agent of acquired immunodeficiency syndrome (AIDS). Our present studies demonstrate that these drugs are broad spectrum antiretroviral agents capable of inhibiting
Nicolas Sluis-Cremer et al.
Antimicrobial agents and chemotherapy, 53(9), 3715-3719 (2009-07-15)
Although the approved nucleoside reverse transcriptase (RT) inhibitors (NRTI) are integral components of therapy for human immunodeficiency virus type 1 (HIV-1) infection, they can have significant limitations, including the selection of NRTI-resistant HIV-1 and cellular toxicity. Accordingly, there is a
H Mitsuya et al.
Proceedings of the National Academy of Sciences of the United States of America, 83(6), 1911-1915 (1986-03-01)
Human T-lymphotropic virus type III (HTLV-III)/lymphadenopathy-associated virus (LAV) is a a newly discovered lymphotropic retrovirus that is cytopathic for helper/inducer T cells in vitro. This virus is the etiologic agent of the acquired immunodeficiency syndrome and related diseases. In the

Global Trade Item Number

SKUGTIN
850715P-500MG04061835231188
850715P-25MG04061835231171
850715P-1G04061835231157
850715P-200MG04061835231164
P3531-100MG04061834368106
P3531-500MG04061834368113

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service